Biologics for rheumatoid arthritis
47 results
1 - 47
Biologics for rheumatoid arthritis - Biologics for people with rheumatoid arthritis naive to methotrexate
- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics
Biologics for rheumatoid arthritis: an overview of Cochrane reviews- Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
- Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis New
- Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis New
- Rheumatoid arthritis
- Biologic interventions for fatigue in rheumatoid arthritis: Cochrane systematic review
- Abatacept for rheumatoid arthritis Edited (no change to conclusions)
- Tocilizumab for rheumatoid arthritis: Cochrane systematic review
- Golimumab for rheumatoid arthritis: Cochrane systematic review
- Anakinra for rheumatoid arthritis: Cochrane systematic review
- Juvenile idiopathic arthritis (juvenile rheumatoid arthritis)
- Rituximab for rheumatoid arthritis: Cochrane systematic review
- Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA) New
- Abatacept for rheumatoid arthritis
Zoster vaccine not associated with increased risk of HZ infection in immune-mediated disease patients- Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis New
- Combination therapy in rheumatoid arthritis
- Biologicals improve outcomes in patients with RA
- Adverse effects of biologics: a network meta‐analysis and Cochrane overview Edited (no change to conclusions)
- Certolizumab pegol (CDP870) for rheumatoid arthritis in adults New search for studies and content updated (no change to conclusions)
- Antidepressants for pain management in rheumatoid arthritis: Cochrane systematic review
- Systemic diseases in pregnancy